Erick Suárez1, Lorena González2, Carlos Pérez-Mitchell3, Ana P Ortiz4, Maricarmen Ramírez-Sola5, Jaime Acosta6, Raúl D Bernabe-Dones7, Carlos González-Aquino8, Ingrid Montes-Rodríguez9, Carmen L Cadilla10. 1. Department of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, PR. 2. Puerto Rico Clinical and Translational Research Consortium, University of Puerto Rico Medical Sciences Campus, San Juan, PR. 3. Center for Cranial Base, Head, and Neck Surgery, HIMA Health San Pablo Group, Caguas, PR; Department of Otolaryngology, School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR. 4. Department of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, PR; University of Puerto Rico Comprehensive Cancer Center, San Juan, PR. 5. Cancer Center of HIMA Health San Pablo Group, Caguas, PR. 6. Center for Cranial Base, Head, and Neck Surgery, HIMA Health San Pablo Group, Caguas, PR. 7. University of Puerto Rico Comprehensive Cancer Center, San Juan, PR; School of Health Professions, University of Puerto Rico Medical Sciences Campus, San Juan, PR. 8. Department of Otolaryngology, School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR. 9. Department of Chemistry, University of Puerto Rico Mayagüez Campus. 10. Department of Biochemistry, School of Medicine and RCMI Center for Genomics in Health Disparities and Rare Diseases, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
Abstract
OBJECTIVE: The incidence of oral cavity and pharyngeal cancer in Puerto Rican men is higher than it is in the men of any other ethnic/racial group in the United States of America (US). The information regarding the effect of the human papilloma virus (HPV) in the gene-expression profile among patients with this cancer is limited in Hispanic community. We aim to describe the methodology for future studies to identify the molecular networks for determining overrepresented signaling and metabolic canonical pathways, based on the differential gene-expression profiles of HPV+ and HPV- samples from patients with oropharyngeal squamous cell carcinoma in Puerto Rico. METHODS: We analyzed the RNA expression of 5 tissue samples from subjects diagnosed with oropharyngeal squamous cell carcinoma, 2 HPV+ and 3 HPV-, using Affymetrix GeneChips. The relative difference between the average gene expressions of the HPV+ and HPV- samples was assessed, based on the fold change (log2-scale). RESULTS: Our analysis revealed 10 up regulated molecules (Mup1, LRP1, P14KA, ALYREF, and BHMT) and 5 down regulated ones (PSME4, KEAP1, ELK3, FAM186B, and PRELID1), at a cutoff of 1.5-fold change. Ingenuity Pathway Analysis showed the following biological functions to be affected in the HPV+ samples: cancer, hematological disease, and RNA post-transcriptional modification. QRT-PCR analysis confirmed only the differential regulation of ALYREF, KEAP1, and FAM186B genes. CONCLUSION: The relevant methodological procedures described are sufficient to detect the most significant biological functions and pathways according to the HPV status in patients with oropharyngeal cancer in Puerto Rico.
OBJECTIVE: The incidence of oral cavity and pharyngeal cancer in Puerto Rican men is higher than it is in the men of any other ethnic/racial group in the United States of America (US). The information regarding the effect of the human papilloma virus (HPV) in the gene-expression profile among patients with this cancer is limited in Hispanic community. We aim to describe the methodology for future studies to identify the molecular networks for determining overrepresented signaling and metabolic canonical pathways, based on the differential gene-expression profiles of HPV+ and HPV- samples from patients with oropharyngeal squamous cell carcinoma in Puerto Rico. METHODS: We analyzed the RNA expression of 5 tissue samples from subjects diagnosed with oropharyngeal squamous cell carcinoma, 2 HPV+ and 3 HPV-, using Affymetrix GeneChips. The relative difference between the average gene expressions of the HPV+ and HPV- samples was assessed, based on the fold change (log2-scale). RESULTS: Our analysis revealed 10 up regulated molecules (Mup1, LRP1, P14KA, ALYREF, and BHMT) and 5 down regulated ones (PSME4, KEAP1, ELK3, FAM186B, and PRELID1), at a cutoff of 1.5-fold change. Ingenuity Pathway Analysis showed the following biological functions to be affected in the HPV+ samples: cancer, hematological disease, and RNA post-transcriptional modification. QRT-PCR analysis confirmed only the differential regulation of ALYREF, KEAP1, and FAM186B genes. CONCLUSION: The relevant methodological procedures described are sufficient to detect the most significant biological functions and pathways according to the HPV status in patients with oropharyngeal cancer in Puerto Rico.
Authors: P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: Maura L Gillison; Tatevik Broutian; Robert K L Pickard; Zhen-you Tong; Weihong Xiao; Lisa Kahle; Barry I Graubard; Anil K Chaturvedi Journal: JAMA Date: 2012-01-26 Impact factor: 56.272
Authors: R B Hayes; E Bravo-Otero; D V Kleinman; L M Brown; J F Fraumeni; L C Harty; D M Winn Journal: Cancer Causes Control Date: 1999-02 Impact factor: 2.506
Authors: Mariela Torres-Cintrón; Ana P Ortiz; Javier Pérez-Irizarry; Marievelisse Soto-Salgado; Nayda R Figueroa-Vallés; Taína De La Torre-Feliciano; Karen J Ortiz-Ortiz; William A Calo; Erick Suárez-Pérez Journal: P R Health Sci J Date: 2010-09 Impact factor: 0.705
Authors: Dana Holzinger; Christa Flechtenmacher; Nataly Henfling; Ines Kaden; Niels Grabe; Bernd Lahrmann; Markus Schmitt; Jochen Hess; Michael Pawlita; Franz X Bosch Journal: Int J Cancer Date: 2013-03-29 Impact factor: 7.396
Authors: Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison Journal: J Natl Cancer Inst Date: 2008-02-12 Impact factor: 13.506
Authors: Pawadee Lohavanichbutr; John Houck; Wenhong Fan; Bevan Yueh; Eduardo Mendez; Neal Futran; David R Doody; Melissa P Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao; Chu Chen Journal: Arch Otolaryngol Head Neck Surg Date: 2009-02
Authors: Maura L Gillison; Xavier Castellsagué; Anil Chaturvedi; Marc T Goodman; Peter Snijders; Massimo Tommasino; Marc Arbyn; Silvia Franceschi Journal: Int J Cancer Date: 2013-08-05 Impact factor: 7.396
Authors: Erick Suárez; William A Calo; Eduardo Y Hernández; Elba C Diaz; Nayda R Figueroa; Ana P Ortiz Journal: BMC Cancer Date: 2009-04-28 Impact factor: 4.430